Showing results (91-100 of 199) with videos related to
Sort By:
Pageof 20
European Journal of Clinical Pharmacology|November 14, 1977
Pharmacokinetics of atenolol in patients with renal impairmentJ Sassard, N Pozet, J McAinsh, et al.Comparative Biochemistry and Physiology. Comparative Physiology|May 1, 1993
Atrial natriuretic factor: plasma concentration and specific binding to renal glomeruli during the development of genetic hypertension in rats of the Lyon strainG Gauquelin, J Gutkowska, M Vincent, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 1, 1997
Genetics of blood pressure and associated phenotypes in the Lyon ratJ Sassard, M Vincent, V Oréa, et al.International Journal of Environmental Analytical Chemistry|January 1, 1986
Routine analysis of catecholamines and metabolites in urine by a liquid chromatographic column switching systemC Rodriguez, N Bernard, C Julien, et al.European Journal of Pharmacology|September 15, 1979
Dihydralazine and catecholamine-synthesizing enzymes in spontaneous hypertensionL Denoroy, B Renaud, M Vincent, et al.Experientia|October 15, 1980
Serum dopamine-beta-hydroxylase activity in a new strain of spontaneously hypertensive ratsS Affara, L Denoroy, B Renaud, et al.Fundamental & Clinical Pharmacology|January 1, 1987
Magnesuria induced by thiazides and the influence of triamtereneM Labeeuw, N Pozet, P Zech, et al.Journal of Hypertension|March 1, 1996
Left ventricular weight but not blood pressure is associated with sex chromosomes in Lyon ratsM Vincent, G Hadour, V Oréa, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 1, 1997
Renin secretion in Lyon hypertensive ratsC Julien, S Bertolino, I A Medeiros, et al.Journal De Pharmacologie|January 1, 1983
[Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient]J Sassard, P Y Zech, N Pozet, et al.Pageof 20